The 556 Morris Avenue site includes research and development facilities, laboratory and support buildings, manufacturing capabilities, storage, warehouse buildings and administrative office space. The site has approximately 850,000 square feet of administrative office space and 450,000 square feet of R&D space.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit www.celgene.com. Follow Celgene on Twitter @Celgene, and on Pinterest and LinkedIn.
For inquiries, please contact: Greg Geissman, Director Public Relations, 908-673-9854.